VIR - Vir Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VIR is currently covered by 9 analysts with an average price target of $22.03. This is a potential upside of $11.33 (105.89%) from yesterday's end of day stock price of $10.7.

Vir Biotechnology's activity chart (see below) currently has 57 price targets and 67 ratings on display. The stock rating distribution of VIR is 10% SELL, 66.67% BUY and 23.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.92% with an average time for these price targets to be met of 150.08 days.

Highest price target for VIR is $110, Lowest price target is $12, average price target is $22.03.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 05-Jun-2024. First documented stock forecast 05-Nov-2019.

Currently out of the existing stock ratings of VIR, 3 are a SELL (10%), 20 are a BUY (66.67%), 7 are a HOLD (23.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

110

$99.97 (996.71%)

110

1 months 21 days ago

1/10 (10%)

$97.34 (768.88%)

128

Buy

19

$8.97 (89.43%)

15

1 months 21 days ago

0/11 (0%)

$6.34 (50.08%)

Hold

12

$1.97 (19.64%)

10

2 months 23 days ago

3/5 (60%)

$1.61 (15.50%)

21

12

$1.97 (19.64%)

15

8 months 20 days ago

2/3 (66.67%)

$3.37 (39.05%)

108

Hold

14

$3.97 (39.58%)

55

10 months 18 days ago

1/2 (50%)

$3 (27.27%)

113

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VIR (Vir Biotechnology) average time for price targets to be met?

On average it took 150.08 days on average for the stock forecasts to be realized with a an average price target met ratio 57.92

Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VIR (Vir Biotechnology)?

Anupam Rama works at JPMORGAN and has 8 price targets and 5 ratings on VIR

Which analyst is the currently most bullish on VIR (Vir Biotechnology)?

Patrick Trucchio with highest potential upside - $99.97

Which analyst is the currently most reserved on VIR (Vir Biotechnology)?

Eric Joseph with lowest potential downside - $1.97

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?